In addition to improving diagnostic accuracy and reproducibility, the use of p16INK4a  immunohistochemistry may help in identifying CIN1 lesions that are associated with HR-HPV types; these lesions are at an increased risk for progression to high-grade dysplasia or carcinoma [49]. Here, CDKN2A is linked to dysplasia.